Literature DB >> 10524857

Squalene-induced extrinsic lipoid pneumonia: serial radiologic findings in nine patients.

J Y Lee1, K S Lee, T S Kim, H K Yoon, B K Han, J Han, M P Chung, O J Kwon.   

Abstract

PURPOSE: The purpose of this work was to demonstrate the initial and follow-up radiologic findings of squalene-induced extrinsic lipoid pneumonia.
METHOD: Follow-up chest radiographs (n = 9) and high-resolution CT scans (n = 3) as well as initial radiographs (n = 9) and CT scans (n = 8) were obtained in nine patients with squalene-induced extrinsic lipoid pneumonia. The serial radiologic findings were analyzed retrospectively by three chest radiologists, focusing on the pattern and distribution of parenchymal abnormalities.
RESULTS: The most frequent pattern of parenchymal abnormalities on chest radiograph was areas of ground-glass opacity (n = 9, bilateral 6), followed by consolidation (n = 7, bilateral 3) and poorly defined small nodules (n = 4, bilateral 2). The abnormalities were distributed in the right lower lung (n = 9), left lower lung (n = 6), and right middle lung (n = 6) zones. Initial CT scans (n = 8) demonstrated bilateral areas of ground-glass attenuation (n = 8), poorly defined centrilobular nodules (n = 8), crazy paving (n = 6), and consolidation (n = 3). The abnormalities were distributed in the right middle lobe (n = 8) and in both lower lobes (n = 5). Follow-up chest radiograph (n = 9) showed complete disappearance (n = 2) and decrease (n = 7) in the extent of the parenchymal abnormalities. Follow-up CT scans (n = 3) demonstrated decrease (n = 2) and no change (n = 1) in the extent of the abnormalities.
CONCLUSION: Squalene-induced extrinsic lipoid pneumonia most commonly appears as areas of ground-glass attenuation mixed with poorly defined centrilobular nodules and crazy paving on CT, being distributed mainly in the right middle and both lower lobes. The lesions are indolent and remain after cessation of squalene ingestion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524857     DOI: 10.1097/00004728-199909000-00018

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

1.  Endogenous lipoid pneumonia presenting as solitary pulmonary nodule: a case report.

Authors:  Jian Lin; Ling-Ling Huang; Jian-Wei Zhang; Min-Hua Ye; Jia-Xi Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Squalene aspiration pneumonia in children: radiographic and CT findings as the first clue to diagnosis.

Authors:  Kyoung Ho Lee; Woo Sun Kim; Jung-Eun Cheon; Joon Beom Seo; In-One Kim; Kyung Mo Yeon
Journal:  Pediatr Radiol       Date:  2005-04-02

3.  Lipoid pneumonia in children following aspiration of mineral oil used in the treatment of constipation: high-resolution CT findings in 17 patients.

Authors:  Gláucia Zanetti; Edson Marchiori; Taisa Davaus Gasparetto; Dante L Escuissato; Arthur Soares Souza
Journal:  Pediatr Radiol       Date:  2007-09-18

4.  Exogenous lipoid pneumonia (ELP): when radiologist makes the difference.

Authors:  G Rea; F Perna; G Calabrese; A Molino; T Valente; A Vatrella
Journal:  Transl Med UniSa       Date:  2016-05-16

Review 5.  Pulmonary melanoma and "crazy paving" patterns in chest images: a case report and literature review.

Authors:  Yikuan Feng; Jianping Zhao; Qun Yang; Weining Xiong; Guohua Zhen; Yongjian Xu; Zhenxiang Zhang; Huilan Zhang
Journal:  BMC Cancer       Date:  2016-08-03       Impact factor: 4.430

6.  Exogenous lipoid pneumonia in children: A systematic review.

Authors:  Diana Marangu; Diane Gray; Aneesa Vanker; Marco Zampoli
Journal:  Paediatr Respir Rev       Date:  2019-01-20       Impact factor: 2.726

7.  False positive 18FDG PET-CT results due to exogenous lipoid pneumonia secondary to oily drug inhalation: A case report.

Authors:  David Chardin; Guillaume Nivaggioni; Philippe Viau; Caherine Butori; Bernard Padovani; Caroline Grangeon-Chapon; Micheline Razzouk-Cadet
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.